Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Matvey, M Tsyganov"'
Publikováno v:
African Journal of Urology, Vol 30, Iss 1, Pp 1-11 (2024)
Abstract Background The aim of this study was to evaluate data over the past 25 years to assess the prevalence of the virus in patients with bladder cancer and to evaluate the association between human papillomavirus (HPV) and bladder cancer risk. Ma
Externí odkaz:
https://doaj.org/article/de9e241e841e48ecae52441ed4d095c9
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract The involvement of human papillomavirus (HPV) in the prostate carcinogenesis is a controversial issue. The presented meta-analysis was carried out to systematize the currently available research results regarding this question. The meta-anal
Externí odkaz:
https://doaj.org/article/4c95b4576d104e9d94b246a3ed6806d9
Autor:
Matvey M. Tsyganov, Marina K. Ibragimova, Evgeniy O. Rodionov, Olga V. Cheremisina, Sergei V. Miller, Sergei A. Tuzikov, Nikolai V. Litvyakov
Publikováno v:
Microorganisms, Vol 11, Iss 1, p 212 (2023)
The significance of the role of human papillomavirus (HPV) in the development of lung cancer remains an open question. The data from the literature do not provide conclusive evidence of HPV being involved in the pathogenesis of lung cancer. The aim o
Externí odkaz:
https://doaj.org/article/98e50b56491246ef9063e8ebb520b78d
Autor:
Matvey M. Tsyganov, Marina K. Ibragimova, Kseniya A. Gaptulbarova, Irina A. Tsydenova, Daria S. Dolgasheva, Evgeniy Y. Garbukov, Anastasia A. Frolova, Elena M. Slonimskaya, Nikolai V. Litvyakov
Publikováno v:
Pharmaceutics, Vol 14, Iss 5, p 948 (2022)
One of the important reasons for the ineffectiveness of chemotherapy in breast cancer (BC) is considered to be the formation of a multidrug resistance phenotype in tumour cells, which is caused by the expression of energy-dependent ABC transporters.
Externí odkaz:
https://doaj.org/article/1d4be1ae403a42a4a96b20d8660cab9b
Autor:
Matvey M. Tsyganov, Marina K. Ibragimova, Evgeniy Yu. Garbukov, Irina A. Tsydenova, Kseniya A. Gaptulbarova, Daria S. Dolgasheva, Ekaterina A. Zdereva, Anastasia A. Frolova, Elena M. Slonimskaya, Nikolai V. Litviakov
Publikováno v:
Diagnostics, Vol 12, Iss 2, p 405 (2022)
Increasingly, many researchers are focusing on the sensitivity in breast tumors (BC) to certain chemotherapy drugs and have personalized their research based on the assessment of this sensitivity. One such personalized approach is to assess the chemo
Externí odkaz:
https://doaj.org/article/fd6667054e22436381698bc54a4714d2
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 22; Pages: 13906
The assessment of molecular genetic landscape changes during NAC and the relationship between molecular signatures in residual tumors are promising approaches for identifying effective markers of outcome in breast cancer. The majority of the data in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f385b30600e9e62bb866f55a79df36c7
https://pubmed.ncbi.nlm.nih.gov/36430403
https://pubmed.ncbi.nlm.nih.gov/36430403
Autor:
Matvey M. Tsyganov, Evgeny O. Rodionov, Marina K. Ibragimova, Sergey V. Miller, Olga V. Cheremisina, Irina G. Frolova, Sergey A. Tuzikov, Nikolai V. Litviakov
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 10; Pages: 1647
Objectives: A growing body of evidence suggests the important role of chemosensitive gene expression in the prognosis of patients with lung cancer. However, studies on combined gene expression assessments for personalized prescriptions of chemotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db3dab6042fee21f91ec86d9ff3fb581
Autor:
Vladimir O. Sigin, Alexey I. Kalinkin, Alexandra F. Nikolaeva, Ekaterina O. Ignatova, Ekaterina B. Kuznetsova, Galina G. Chesnokova, Nikolai V. Litviakov, Matvey M. Tsyganov, Marina K. Ibragimova, Ilya I. Vinogradov, Maxim I. Vinogradov, Igor Y. Vinogradov, Dmitry V. Zaletaev, Marina V. Nemtsova, Sergey I. Kutsev, Alexander S. Tanas, Vladimir V. Strelnikov
Publikováno v:
Cancers; Volume 15; Issue 5; Pages: 1630
Despite advances in the diagnosis and treatment of breast cancer (BC), the main cause of deaths is resistance to existing therapies. An approach to improve the effectiveness of therapy in patients with aggressive BC subtypes is neoadjuvant chemothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ef7f03d73ecf4dc38b00694b2b83ab
https://doi.org/10.3390/cancers15051630
https://doi.org/10.3390/cancers15051630
Publikováno v:
Anticancer Research. 41:187-195
Background Amplification of chromosome 8q with locus 8q24 is the most common copy number aberration, and is associated with tumour progression and chemoresistance. Materials and methods The study used paired samples of biopsy and surgical material fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::698f38142d0a72234cecf081c92b190a
https://doi.org/10.21873/anticanres.14764
https://doi.org/10.21873/anticanres.14764
Autor:
Elena M. Slonimskaya, Matvey M. Tsyganov, Nikolai V. Litviakov, M.K. Ibragimova, E.Y. Garbukov, A. V. Doroshenko
Publikováno v:
Current Cancer Drug Targets. 20:681-688
Background: In this study, we examined the CNA-genetic landscape (CNA – copy number aberration) of breast cancer prior to and following neoadjuvant chemotherapy (NAC) and correlated changes in the tumor landscape with chemotherapy efficiency as wel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f81ba9b3af53fe67c7f0ddf98a5a30d
https://doi.org/10.2174/1568009620666200506104523
https://doi.org/10.2174/1568009620666200506104523